Home > Insider Trading > Filing (0001562180-21-005712)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583648	Pieris Pharmaceuticals Inc.	PIRS	Pharmaceutical Preparations (2834)	300784346

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1875416	Shane Olwill	C/O Pieris Pharmaceuticals, Inc. 255 State Street, 9Th Floor Boston MA 02109	Chief Development Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-30	38,400	$1.52	43,038	No	4	M	Direct
Common Stock	Disposition	2021-08-30	9,200	$5.00	33,838	No	4	S	Direct
Common Stock	Disposition	2021-08-30	29,200	$5.15	4,638	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-08-30	38,400	$0.00	100,000	$1.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
61,600		2026-02-12	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The option has fully vested.